• Explore /
  • Poster
  • / Safety and efficacy of temsirolimus as second-line treatment for patients with recurrent bladder cancer.

Safety and efficacy of temsirolimus as second-line treatment for patients with recurrent bladder cancer.

Abstract Poster

Authors

null

Nadine Houede

Centre Hospitalier Régional Universitaire, Nîmes, France

Nadine Houede , Guilhem Roubaud , Hakim Mahammedi , Lionel Vedrine , Florence Joly , Loic Mourey , Christian Pfister , Stephane Culine , Alejandro Goberna , Barbara Lortal , Marina Pulido , Philippe Pourquier , Carine A. Bellera

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT0187943NCT0187943

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 304)

DOI

10.1200/jco.2015.33.7_suppl.304

Abstract #

304

Poster Bd #

E15

Abstract Disclosures

Similar Posters

First Author: Jiwon Lee

First Author: Jianqing Zhu

First Author: Wensi Zhao

First Author: Sheng Li